Tap Into a Global Network of Leading CNS Drug Delivery Innovators, Forge Strategic Partnerships & Accelerate the Future of Brain Therapeutics
With the CNS delivery field at a pivotal inflection point, investment is surging as clinical validation of BBB-crossing technologies fuels a new wave of partnerships, platform deals, and acquisitions. Milestones including Denali's FDA-approved CNS Transport Vehicle™ platform, Roche's Brainshuttle™ programs, Roche's $2 billion agreement with Manifold Bio, Novartis' partnerships with SciNeuro and Sironax, and Korsana Biosciences' $175 million financing underscore growing confidence in next-generation brain delivery technologies.
As BBB shuttles, CNS-targeted biologics, oligonucleotides, gene therapies, and novel delivery platforms advance into the clinic, demand for outsourced expertise is rapidly increasing. Drug developers are actively investing in preclinical CROs, advanced BBB models, imaging and brain-monitoring technologies, biodistribution analytics, manufacturing partners, and delivery platform collaborations to accelerate clinical success. The 8th CNS Drug Delivery Summit will unite 100+ senior leaders from pharma, biotech, academia, and solution providers seeking the technologies, services, and partnerships needed to advance the next generation of CNS therapeutics.
Are you looking to position your organization at the center of one of biopharma's hottest investment areas and become a trusted partner in solving the challenge of brain delivery?
What to Expect
Connect with CNS Drug Delivery Leaders
Accelerate high-value partnerships through curated networking and 1-to-1 meetings with pharma, biotech, academic, and technology leaders advancing brain delivery innovation.
Navigate the Next Frontier of Brain Delivery
Stay ahead of emerging delivery technologies, BBB-crossing strategies, novel modalities, and translational approaches shaping the future of CNS therapeutics.
Showcase Your Solutions & Stand Out
Demonstrate your expertise across drug delivery platforms, brain-targeting technologies, biomarker tools, and translational services to become a partner of choice for CNS developers.
Key Services & Solutions
Preclinical CROs supporting brain-targeted drug development with specialized dosing, PK/PD, biodistribution, and efficacy studies that de-risk CNS programs before the clinic.
Brain Monitoring & Imaging leveraging advanced imaging, EEG, and microscopy technologies to quantify brain exposure, map biodistribution, and validate therapeutic delivery.
BBB Shuttles & Delivery Platforms developing innovative carrier technologies and delivery platforms that enable therapeutics to reach the CNS following systemic administration.
Molecular Discovery & Engineering designing and optimize antibodies, oligonucleotides, proteins, and viral vectors specifically engineered for efficient brain delivery and CNS targeting.
Recognize yourself and your business priorities in this description? With speaking and exhibitor inventory already running low, don’t hesitate to reach out for more information on partnership packages, attendee lists and create a bespoke package that aligns with your goals together. Or click here to explore who’s already partnered for 2026.
Hear What Our Past Sponsors Have to Say
I really valued, the close interaction with high-quality professionals
Sales & Marketing Senior Scientist, Gubra
Good onsite management, high quality conversations with attendees
Senior Director - Marketing & Business Development, Biomere
Nice mix of industry and academics, range of topics
Global Business Development Director, Aptar Group Inc
The conference was incredibly insightful. I was particularly impressed by the diversity of the topics covered and the depth of the discussions. The organization was impeccable, making it easy to focus on learning and networking
Principal Researcher, ShiftBio
I thought it was a great event, well organized and very on-spot when it comes to gathering experts from the niche area of CNS drug delivery.
What made my experience enjoyable was the great atmosphere, positive and open meet ups, and the way everybody had the same target: accelerate the pace of innovation in treating CNS diseases. This extended to the organizers too, with their insightful questions in between sessions and personal experiences, which made me think the importance of these events and of pushing the boundaries of our expertise
Head Of Biomedical Engineering & CNS Lead, Cambridge Design Partnership
Very good scientific level. Great openness of participants, perfect logistics with appropriate size of event for networking.
CEO, Affilogic
The venue was well organized, and the hospitality provided by the organizers was commendable
Business Development, Marketing Associate, Kenox Pharmaceuticals
Small intimate setting made networking easy
Chief Product Officer, CraniUS LLC
Attending Companies Include
Audience Composition
Company Type
Attendee Seniority
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Hannah Martin
Partnerships Director